RETHINKDEPRESSION Trademark

Trademark Overview


On Friday, November 1, 2024, a trademark application was filed for RETHINKDEPRESSION with the United States Patent and Trademark Office. The USPTO has given the RETHINKDEPRESSION trademark a serial number of 98832290. The federal status of this trademark filing is WITHDRAWN BEFORE PUBLICATION as of Thursday, April 10, 2025. This trademark is owned by H. Lundbeck A/S. The RETHINKDEPRESSION trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Education services, namely, arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of medical research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, including on-line in the form of seminars, conferences, symposiums, workshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders, and pharmaceutical preparations a...

Sanitary preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency on drugs, alcohol, nicotine and caffeine; diagnostic preparations, substances, reagents and agents for medical purposes

Medical services; medical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical consultancy relating to medical and pharmaceutical preparations; medical, clinical, therapeutic clinical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical and therapeutic services relating to the treatment and prevention of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical, clinical, therapeutic clinical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of medical advice and medical information in the field of diagnostics, medicine, drugs, disorders, diseases, treatment and prevention; medical info...

Scientific and technological services, namely, research and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing online non-downloadable software for accessing data and information in the fields of research and development, science, clinical studies, trials and tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; pharmaceutical research and development; scientific and technological services, namely, research and design in the...
rethinkdepression

General Information


Serial Number98832290
Word MarkRETHINKDEPRESSION
Filing DateFriday, November 1, 2024
Status692 - WITHDRAWN BEFORE PUBLICATION
Status DateThursday, April 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesEducation services, namely, arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of medical research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, including on-line in the form of seminars, conferences, symposiums, workshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing on-line training programs in the field of research and development relating to the treatment and prevention of central nervous systems diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of online publications in the nature of books, reports, brochures, booklets, magazines, leaflets, journals, teaching and training materials in the fields of science, clinical trials and tests, diagnostics and medicine; arranging and conducting in-person and online educational expert forums in the fields of science, clinical trials and tests, diagnostics and medicine
Description of MarkThe mark consists of the words "RETHINKDEPRESSION" with a thought cloud over the letter "I." The word "RETHINK" is in blue; the word "DEPRESSION" and the thought cloud are in red. The color white is not claimed as a feature of the mark and represents background.
Goods and ServicesSanitary preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency on drugs, alcohol, nicotine and caffeine; diagnostic preparations, substances, reagents and agents for medical purposes
Pseudo MarkRETHINK DEPRESSION
Indication of Colors claimedThe color(s) red and blue are claimed as a feature of the mark.
Goods and ServicesMedical services; medical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical consultancy relating to medical and pharmaceutical preparations; medical, clinical, therapeutic clinical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical and therapeutic services relating to the treatment and prevention of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical, clinical, therapeutic clinical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of medical advice and medical information in the field of diagnostics, medicine, drugs, disorders, diseases, treatment and prevention; medical information service, namely, provision of medical information related to the medical dosage, diagnosis, therapeutic topics, medical administration, treatment and prevention of central nervous system disorders and diseases, and for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of online medical data and analytics designed to provide patients and clients with tailored information, on medical dosage, diagnoses, therapeutic topics and medical administration
Goods and ServicesScientific and technological services, namely, research and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing online non-downloadable software for accessing data and information in the fields of research and development, science, clinical studies, trials and tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; pharmaceutical research and development; scientific and technological services, namely, research and design in the field of disorders, diseases and prevention; scientific and technological services, namely, research and design in the field of central nervous system stimulants, pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases and drugs; medical and scientific research, namely, conducting clinical trials for others; clinical studies tests and trials; pharmaceutical research and development services; medical research; providing information in the field of research and development related to the treatment and prevention of central nervous system stimulants, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of medical research information in the fields of research and development, science, clinical studies, trials and tests

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, November 1, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 1, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressValby 2500
DK

Trademark Events


Event DateEvent Description
Friday, November 1, 2024NEW APPLICATION ENTERED
Monday, November 18, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, November 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 2, 2024ASSIGNED TO EXAMINER
Thursday, December 5, 2024NON-FINAL ACTION E-MAILED
Thursday, December 5, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 10, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED